Randomized, controlled trial with interferon-alpha plus ribavirin with and without amantadine sulphate in patients with chronic hepatitis C relapsing after previous successful antiviral treatment

被引：2
|
作者：
Teuber, G
Pascu, M
Lafrenz, M
Weidenbach, H
Schoelmrich, J
Wietzke-Braun, P
Arnold, R
Pausch, J
Lock, G
Zeuzem, S
机构：
[1] UNIKlin, Med Klin 2, D-60590 Frankfurt, Germany
[2] Klin & Poliklin Innere Med, D-18055 Rostock, Germany
[3] Univ Klinikum Charite, D-13352 Berlin, Germany
[4] Med UNI Klin, D-89081 Ulm, Germany
[5] UniKlin, Gastroenterol Abt, Gottingen, Germany
[6] UNIKlin, Klin & Poliklin Innere Med, D-93042 Regensburg, Germany
[7] UNIKlin, Zentrum Innere Med, D-35033 Marburg, Germany
[8] Staedt Klinikum, Med Klin 1, D-34125 Kassel, Germany
[9] UNIKlin, Med Klin 2, D-60590 Frankfurt, Germany
来源：
JOURNAL OF HEPATOLOGY | 2002年 / 36卷
关键词：
D O I：
10.1016/S0168-8278(02)80472-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
472
引用
收藏
页码：132 / 132
页数：1
相关论文
共 50 条
  • [41] Commentary: efficacy and safety of ribavirin plus pegylated interferon-alpha in geriatric patients with chronic hepatitis C
    Hadziyannis, S. J.
    Sevastianos, V.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (04) : 491 - 491
  • [42] Interferon induction plus ribavirin and amantadine as a novel approach for treatment of interferon nonresponder chronic hepatitis C patients.
    Adinolfi, LE
    Marracino, M
    Tonziello, A
    Utili, R
    Andreana, A
    Giordano, M
    Ruggiero, G
    HEPATOLOGY, 2000, 32 (04) : 352A - 352A
  • [43] Interferon-alpha and ribavirin alone or in combination with ketoprofen for the treatment of patients with chronic hepatitis C who have not responded to previous interferon therapy.
    Nunes, FA
    Schultz, C
    Santoro, J
    Kaufman, B
    Kenny, R
    Rock, E
    Gasic, A
    Carlson, S
    Griffell, L
    Shields, D
    Matasow, G
    Lucey, MR
    HEPATOLOGY, 1999, 30 (04) : 617A - 617A
  • [44] Induction treatment of chronic hepatitis C with daily interferon plus ribavirin plus amantadine is effective in non-responders to interferon plus ribavirin
    Stauber, R
    Munda-Steindl, P
    Hackl, F
    Schüutze, K
    Datz, C
    Hofer, H
    Hegenbarth, K
    Jessner, W
    Ferenci, P
    JOURNAL OF HEPATOLOGY, 2001, 34 : 134 - 135
  • [45] Interferon-alpha and ribavirin alone or in combination with ketoprofen for the treatment of patients with chronic hepatitis C who have not responded to previous interferon therapy.
    Nunes, FA
    Santoro, J
    Kaufman, B
    Kenny, R
    Rock, E
    Gasic, A
    Carlson, S
    Griffel, L
    Shields, D
    Matusow, G
    O'Toole, W
    Brass, CA
    Lucey, MR
    HEPATOLOGY, 1998, 28 (04) : 579A - 579A
  • [46] RANDOMIZED CONTROLLED TRIAL OF RECOMBINANT INTERFERON-ALPHA(2B) IN THE TREATMENT OF CHINESE PATIENTS WITH CHRONIC HEPATITIS-C
    HWANG, SJ
    CHAN, CY
    LU, RH
    WU, JC
    LEE, SD
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1995, 15 (07): : 611 - 616
  • [47] Interferon-α plus ribavirin in chronic hepatitis C resistant to previous interferon-α course:: results of a randomized multicenter trial
    Andreone, P
    Gramenzi, A
    Cursaro, C
    Sbolli, G
    Fiorino, S
    Di Giammarino, L
    Miniero, R
    D'Errico, A
    Gasbarrini, G
    Bernardi, M
    JOURNAL OF HEPATOLOGY, 1999, 30 (05) : 788 - 793
  • [48] Successful triple combination treatment of patients with chronic hepatitis C not responding to interferon plus ribavirin
    Stauber, R
    Hackl, F
    Schütze, K
    Bauer, B
    Datz, C
    Hubmann, R
    Ferenci, P
    JOURNAL OF HEPATOLOGY, 2000, 32 : 184 - 184
  • [49] Variants in Interferon-Alpha Pathway Genes and Response to Pegylated Interferon-Alpha2a Plus Ribavirin for Treatment of Chronic Hepatitis C Virus Infection in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial
    Welzel, Tania Mara
    Morgan, Timothy R.
    Bonkovsky, Herbert L.
    Naishadham, Deepa
    Pfeiffer, Ruth M.
    Wright, Elizabeth C.
    Hutchinson, Amy A.
    Crenshaw, Andrew T.
    Bashirova, Arman
    Carrington, Mary
    Dotrang, Myhanh
    Sterling, Richard K.
    Lindsay, Karen L.
    Fontana, Robert J.
    Lee, William M.
    Di Bisceglie, Adrian M.
    Ghany, Marc G.
    Gretch, David R.
    Chanock, Stephen J.
    Chung, Raymond T.
    O'Brien, Thomas R.
    HEPATOLOGY, 2009, 49 (06) : 1847 - 1858
  • [50] Use of anxiolytics and antidepressants before and after treatment with interferon-alpha and ribavirin in patients with hepatitis C
    Garcia-Toro, Mauro
    Vilella Martorell, Angels
    Carral Martinez, Maria
    Jimeno Beltran, Teresa
    Roman Ruiz del Moral, Yolanda
    Pradas Guerrero, Carmen
    Gili Planas, Margalida
    Roca Bennasar, Miguel
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2011, 34 (04): : 307 - 308
12345